Clinical Trials Browser

Phase 1/2 × liposomal doxorubicin × 90 days × Clear all

NCT06843447 2026-05-26

MK-5909-003

Phase 1/2 Recruiting

Ovarian Cancer Recurrent

NCT05271318 2026-05-05

PROTA

Phase 1/2 Active not recruiting

Adenoviridae Infections

NCT05610735 2026-03-19

Combination Therapy for Recurrent Ovarian Cancer

Phase 1/2 Recruiting

Ovarian Neoplasms